NEWS

FDA panel endorses Pfizer, Moderna COVID-19 vaccines for kids as young as 6 months old

Updated: June 16, 2022 at 6:57 pm EST  See Comments

Thu Jun 16, 2022 – 6:09 pm EDT

(LifeSiteNews) – The federal government is close to formally approving COVID-19 vaccines for children as young as six months old despite the risks of the shots outweighing the risks of COVID itself for young Americans.

USA Today reported that an “expert panel” for the U.S. Food & Drug Administration (FDA) voted 21-0 on Wednesday that Pfizer and Moderna’s mRNA-based COVID vaccines were safe and effective for children between the ages of six months and six years, one of the only age groups for which the shots have not yet been approved (the last being newborns to six months).

“This will certainly alleviate a lot of their concerns,” said Children’s Mercy Hospital allergist Dr. Jay Portnoy, referring to parents who fear their children contracting COVID. “I think it was the right vote.” Portnoy was the “patient representative on the committee,” USA Today says.

Another panel with the U.S. Centers for Disease Control & Prevention (CDC) will vote on the matter Saturday, with the shots potentially available for the youngest age group yet as soon as next Tuesday.

The FDA’s previous decision to approve administering reduced doses of Pfizer’s COVID

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
Big Berkey Water Filter 2 Gallon System Bundle: 2 Black BB9 Filters, 2 Fluoride PF2 Filters
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.